神州數碼(000034.SZ):截至11日與華為未就榮耀出售一事達成任何協議
格隆匯11月11日丨神州數碼(000034.SZ)公告稱,公司關注到,2020年11月10日,部分媒體以“華為計劃以1000億元出售榮耀品牌給神州數碼”等為題的相關報道,主要內容為華為計劃將榮耀手機業務整體打包出售,神州數碼將作為收購方之一參與。
經核實,公司針對上述報道事項説明如下:截至2020年11月11日,神州數碼與華為未就榮耀出售一事達成任何協議。
截至2020年11月11日,公司不存在根據《深圳證券交易所股票上市規則》等相關法律、法規和規範性文件中所規定的應予以披露而未披露的事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.